Expertise in
10
conditions

Dr. Kamal M. Patel

Radiation Oncology
City Of Hope Chicago
2520 Elisha Ave, 
Zion, IL 
Expertise in
10
conditions
City Of Hope Chicago
2520 Elisha Ave, 
Zion, IL 

Overview

Kamal Patel is a Radiation Oncologist practicing medicine in Zion, Illinois.

Dr. Patel is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC).

He is actively involved in clinical research, co-authoring 7 peer reviewed articles and participating in 7 clinical trials.

Specialties

Radiation Oncology

Licenses

Radiology in IL

Hospital Affiliations

Eisenhower Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

City of Hope Chicago
2520 Elisha Ave, Zion, IL 60099
Other Locations
Eisenhower Health
39000 Bob Hope Dr, Rancho Mirage, CA 92270

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
A Phase II, Open Label, Multi-Dose Study of ⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for Positron Emission Tomography (PET/CT) in Patients With Selected Advanced or Metastatic Solid Malignancies Who Are Scheduled to Receive Standard-of-Care Immunotherapy Only, As Single Agent or in Combination
A Phase II, Open Label, Multi-Dose Study of ⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for Positron Emission Tomography (PET/CT) in Patients With Selected Advanced or Metastatic Solid Malignancies Who Are Scheduled to Receive Standard-of-Care Immunotherapy Only, As Single Agent or in Combination
Enrollment Status: Completed
Publish Date: July 09, 2024
Intervention Type: Drug
Study Drug: 89Zr-Df-IAB22M2C
Study Phase: Phase 2
Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer
Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer
Enrollment Status: Completed
Publish Date: February 07, 2024
Intervention Type: Diagnostic test
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Enrollment Status: Completed
Publish Date: September 01, 2022
Intervention Type: Other
Stool Collection Sub-Study of Exact Sciences Protocol 2018-01: Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Stool Collection Sub-Study of Exact Sciences Protocol 2018-01: Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Enrollment Status: Completed
Publish Date: June 06, 2022
Intervention Type: Other
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma
Enrollment Status: Terminated
Publish Date: February 10, 2021
Intervention Type: Other
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies
Enrollment Status: Terminated
Publish Date: February 03, 2021
Intervention Type: Other
View 6 Less Clinical Trials

7 Total Publications

Circulating Tumor DNA Genotyping of Intrinsic and Acquired Gene Alterations in Patients With Advanced Breast Cancer Receiving Palbociclib: Biomarker Results From POLARIS Study.
Circulating Tumor DNA Genotyping of Intrinsic and Acquired Gene Alterations in Patients With Advanced Breast Cancer Receiving Palbociclib: Biomarker Results From POLARIS Study.
Journal: JCO precision oncology
Published: August 18, 2025
Similar Doctors
Expertise in
35
conditions
Dr. Vinai Gondi
Radiation Oncology
Expertise in
35
conditions
Dr. Vinai Gondi
Radiation Oncology
Referral may be required
Before you request

Northwestern Medicine Cancer Center Warrenville

4405 Weaver Pkwy, 
Warrenville, IL 
 (47.6 miles away)
Experience:
19+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Vinai Gondi is a Radiation Oncologist practicing medicine in Warrenville, Illinois. He has been practicing medicine for over 19 years. Dr. Gondi is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Astrocytoma, Glioblastoma, Glioma, and Gamma Knife Radiosurgery. Dr. Gondi is board certified in American Board Of Radiology - Radiation Oncology (Certified). Dr. Gondi is currently accepting new patients.

Expertise in
11
conditions
Dr. Stanley L. Liauw
Radiation Oncology
Expertise in
11
conditions
Dr. Stanley L. Liauw
Radiation Oncology
Referral may be required

UChicago Medicine Duchossois Center For Advanced Medicine - Hyde Park

5758 S. Maryland Ave., 
Chicago, IL 
 (46.9 miles away)
888-824-0200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Stanley Liauw is a Radiation Oncologist practicing medicine in Chicago, Illinois. Dr. Liauw is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Squamous Cell Carcinoma of the Anal Canal (SCAC), Anal Cancer, Prostatectomy, and Nephrectomy. Dr. Liauw is board certified in Practicing Since2006 and Radiation Oncology. Dr. Liauw is currently accepting new patients.

Expertise in
2
conditions
Dr. Parthiv S. Mehta
Radiation Oncology
Expertise in
2
conditions
Dr. Parthiv S. Mehta
Radiation Oncology
Referral may be required

UroPartners Cancer Treatment Center Glenview

2600 Patriot Blvd Unit J, 
Glenview, IL 
 (24.6 miles away)
224-260-3100
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Parthiv Mehta is a Radiation Oncologist practicing medicine in Glenview, Illinois. Dr. Mehta is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Prostate Cancer and Familial Prostate Cancer. Dr. Mehta is currently accepting new patients.

Frequently Asked Questions about Dr. Kamal M. Patel

How do I make an appointment with Dr. Kamal M. Patel?

You can book an appointment with Dr. Kamal M. Patel by calling their office at 760-674-3600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kamal M. Patel a top-rated expert for Familial Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kamal M. Patel is classified as an Advanced expert for Familial Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kamal M. Patel specialize in?

While Dr. Kamal M. Patel is a Radiation Oncology, they have specific expertise in Familial Prostate Cancer, Lung Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Kamal M. Patel participate in research or clinical trials?

Yes. Dr. Kamal M. Patel has published 7 articles and abstracts on conditions like Familial Prostate Cancer. You can view a list of Dr. Kamal M. Patel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kamal M. Patel accept my insurance?

Dr. Kamal M. Patel accepts most major insurance plans, including Anthem BCBS and Blue Shield of California. We recommend calling the office directly at 760-674-3600 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Patel's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 34 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile